DiaKine Therapeutics' Other Investors

DiaKine Therapeutics raised a round of funding on , .

DiaKine Therapeutics, Inc. is a development-stage company commercializing immune modulators such as Lisofylline (LSF) and related oral compounds into therapies for diabetes and related complications. …

Articles about DiaKine Therapeutics' Other Investors: